MATERNAL-INFANT TRANSMISSION AND MICROBIAL DYNAMICS OF GROUP B STREPTOCOCCUS: A COMPREHENSIVE STUDY IN A TERTIARY CARE SETTING

Main Article Content

Dr. Dipti Shukla
Dr. Mohammad Noor Alam Khan
Dr. Rajdeep Paul
Dr. Kanupriya Tiwari
Dr. Kuldeep Singh

Keywords

Group B Streptococcus, maternal-infant transmission, microbial dynamics, neonatal infection, intrapartum antibiotic prophylaxis

Abstract

Group B Streptococcus (GBS) remains a significant cause of neonatal morbidity and mortality. This study investigates the maternal-infant transmission and microbial dynamics of GBS in a tertiary care setting. We conducted a prospective study involving pregnant women and their newborns, analyzing colonization rates, transmission pathways, and the impact of intrapartum antibiotic prophylaxis (IAP). The study included 500 pregnant women at 35-37 weeks of gestation and their newborns. Maternal colonization was assessed through vaginal and rectal swabs, while neonatal colonization was determined using ear canal, nasopharynx, and rectum swabs. The overall maternal colonization rate was 24%, with significant risk factors including urinary tract infections, multiple pregnancies, and diabetes. Neonatal colonization was observed in 25% of infants born to colonized mothers, with a higher transmission rate among those whose mothers did not receive IAP. The predominant GBS serotypes were III, Ia, and V, and clonal relationships between maternal and neonatal isolates were identified, indicating vertical transmission. IAP significantly reduced neonatal colonization and infection rates. Our findings underscore the importance of effective screening and prevention strategies to mitigate the risk of GBS transmission and subsequent neonatal infections.

Abstract 115 | Pdf Downloads 34

References

1. Verani, J. R., McGee, L., Schrag, S. J., & Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention. (2010). Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm Rep, 59(RR-10), 1-36.
2. Baker, C. J., & Edwards, M. S. (2022). Group B Streptococcal Infections. In Infectious Diseases of the Fetus and Newborn Infant (8th ed.). Elsevier.
3. Puopolo, K. M., Lynfield, R., & Cummings, J. J. (2019). Management of infants at risk for group B Streptococcal disease. Pediatrics, 144(2), e20191881.
4. Berardi, A., Spada, C., Reggiani, M. L. B., & et al. (2013). Group B Streptococcus late-onset disease: 2003-2010. Pediatrics, 131(2), e361-e368.
5. Rajagopal, L. (2009). Understanding the regulation of group B Streptococcal virulence factors. Future Microbiol, 4(2), 201-221.
6. Edmond, K. M., Kortsalioudaki, C., Scott, S., et al. (2012). Group B Streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet, 379(9815), 547-556.
7. Stoll, B. J., Hansen, N. I., Sánchez, P. J., et al. (2011). Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics, 127(5), 817-826.
8. Tazi, A., Morand, P. C., Réglier-Poupet, H., et al. (2010). Invasive group B Streptococcal infections in adults. Emerging Infectious Diseases, 16(6), 843-854.
9. Lu, B., Chen, X., Wang, J., et al. (2014). Molecular characteristics and antimicrobial resistance of invasive and noninvasive group B Streptococcus isolates from Shanghai, China. Int J Infect Dis, 23, 51-58.
10. El Aila, N. A., Tency, I., Claeys, G., et al. (2011). Comparison of different sampling techniques and of different culture methods for detection of group B Streptococcus carriage in pregnant women. BMC Infect Dis, 10, 285.
11. Lin, F. Y., Weisman, L. E., Azimi, P. H., et al. (2011). Antibiotic susceptibility profiles for group B Streptococci isolated from neonates, 1995-1998. Clin Infect Dis, 33(8), 1237-1242.
12. Uh, Y., Jang, I. H., Hwang, G. Y., et al. (1997). Colonization rate of group B Streptococcus in pregnant women and neonates. Korean J Infect Dis, 29(4), 396-403.
13. Dzupova, O., Konvalinka, J., & Chrdle, A. (2014). Group B Streptococcus infections in adults: The role of immunosuppression and diabetes. BMC Infect Dis, 14, 415.
14. Melin, P. (2011). Neonatal group B Streptococcal disease: from pathogenesis to preventive strategies. Clin Microbiol Infect, 17(7), 1037-1045.
15. Phares, C. R., Lynfield, R., Farley, M. M., et al. (2008). Epidemiology of invasive group B Streptococcal disease in the United States, 1999-2005. JAMA, 299(17), 2056-2065.
16. Manning, S. D., Lewis, M. A., Springman, A. C., et al. (2008). Genotypic diversity and serotype distribution of group B Streptococcus isolated from women before and after delivery. Clin Infect Dis, 46(12), 1829-1837.
17. Ippolito, D. L., James, W. A., Tinnemore, D., et al. (2010). Group B Streptococcus in women and newborns: virulence gene distribution and disease associations. J Med Microbiol, 59(Pt 10), 1149-1161.
18. Jones, N., Oliver, K. A., Barry, J., et al. (2006). Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B Streptococcus is independent of capsular serotype. Clin Infect Dis, 42(7), 915-924.
19. Yildirim, H. I., Tuncer, O., Bulut, A., et al. (2010). The prevalence of group B Streptococcus colonization in third trimester pregnancy in Turkish women and related risk factors. J Pak Med Assoc, 60(10), 819-823.
20. Verani, J. R., Spina, N. L., & Schrag, S. J. (2010). Screening and prevention of perinatal group B Streptococcal disease: a global perspective. Future Microbiol, 5(9), 1241-1259.
21. Davies, H. D., Miller, M. A., Faro, S., et al. (2001). Group B Streptococcus colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol, 97(4), 640-645.
22. Melin, P., Efstratiou, A., & European Surveillance Network for Invasive Group B Streptococcal Disease. (2013). Neonatal group B Streptococcal infections: prevention strategies, clinical aspects, and future challenges. Expert Rev Anti Infect Ther, 11(1), 97-110.
23. Hansen, S. M., Uldbjerg, N., & Kilian, M. (2004). Dynamics of Streptococcus agalactiae colonization in women during and after pregnancy and in their infants. J Clin Microbiol, 42(1), 83-89.
24. de-Paris, F., Machado, A. B., Gheno, T. C., et al. (2011). Group B Streptococcus detection: comparison of PCR assay and culture as a screening method for pregnant women. Braz J Infect Dis, 15(4), 323-327.
25. Ji, W., Zhang, L., Guo, Z., et al. (2019). Prevalence and antibiotic resistance of group B Streptococcus in pregnant women in Beijing, China. BMC Infect Dis, 19, 68.
26. Yan, Y., Zhang, H., Liu, X., et al. (2018). Serotype distribution and antibiotic resistance of group B Streptococcus isolated from pregnant women in Beijing, China. Eur J Clin Microbiol Infect Dis, 37(1), 157-163.
27. Edmond, K. M., Kortsalioudaki, C., Scott, S., et al. (2012). Group B Streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet, 379(9815), 547-556.